JP2022551813A5 - - Google Patents
Info
- Publication number
- JP2022551813A5 JP2022551813A5 JP2022515099A JP2022515099A JP2022551813A5 JP 2022551813 A5 JP2022551813 A5 JP 2022551813A5 JP 2022515099 A JP2022515099 A JP 2022515099A JP 2022515099 A JP2022515099 A JP 2022515099A JP 2022551813 A5 JP2022551813 A5 JP 2022551813A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- hrc
- antiviral
- complex according
- peptide complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962895752P | 2019-09-04 | 2019-09-04 | |
| US62/895,752 | 2019-09-04 | ||
| US202062988286P | 2020-03-11 | 2020-03-11 | |
| US62/988,286 | 2020-03-11 | ||
| US202063009883P | 2020-04-14 | 2020-04-14 | |
| US63/009,883 | 2020-04-14 | ||
| PCT/US2020/049473 WO2021046398A2 (en) | 2019-09-04 | 2020-09-04 | Combination antiviral therapy for measles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022551813A JP2022551813A (ja) | 2022-12-14 |
| JP2022551813A5 true JP2022551813A5 (enExample) | 2023-09-13 |
Family
ID=74853434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022515099A Pending JP2022551813A (ja) | 2019-09-04 | 2020-09-04 | 麻疹に対する併用抗ウイルス療法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230014151A1 (enExample) |
| EP (1) | EP4025586A4 (enExample) |
| JP (1) | JP2022551813A (enExample) |
| CN (1) | CN114729007A (enExample) |
| IL (1) | IL291091A (enExample) |
| WO (1) | WO2021046398A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12226474B2 (en) | 2021-01-22 | 2025-02-18 | Decoy Therapeutics Inc. | Methods and compositions for treating infections |
| EP4475868A2 (en) * | 2022-02-07 | 2024-12-18 | Decoy Therapeutics Inc. | Methods and compositions for treating covid infections |
| WO2025085916A1 (en) * | 2023-10-20 | 2025-04-24 | The Trustees Of Columbia University In The City Of New York | Humanized monoclonal antibody and vaccines against measles virus |
| WO2025111546A1 (en) * | 2023-11-22 | 2025-05-30 | Board Of Trustees Of Michigan State University | Development of broad-spectrum anti-opioid vaccines |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1692265T3 (pl) * | 2003-11-04 | 2011-12-30 | The Administrators Of The Tulane Educational Fund | Sposób zapobiegania fuzji wirus:komórka przez hamowanie działania regionu inicjowania fuzji w wirusach RNA zawierających fuzogenne błonowe białka otoczki klasy I |
| CN101687911A (zh) * | 2007-05-16 | 2010-03-31 | 康久化学生物技术公司 | 抗病毒肽的半胱磺酸衍生物 |
| US20130196903A1 (en) * | 2010-08-11 | 2013-08-01 | Jv Bio Srl | Multimeric Inhibitors of Viral Fusion and Uses Thereof |
| US10172961B2 (en) * | 2014-05-07 | 2019-01-08 | Cornell University | Inhibitors of fusion between viral and cell membranes as well as compositions and methods of using them |
-
2020
- 2020-09-04 CN CN202080077668.XA patent/CN114729007A/zh active Pending
- 2020-09-04 JP JP2022515099A patent/JP2022551813A/ja active Pending
- 2020-09-04 US US17/640,327 patent/US20230014151A1/en active Pending
- 2020-09-04 WO PCT/US2020/049473 patent/WO2021046398A2/en not_active Ceased
- 2020-09-04 EP EP20861697.9A patent/EP4025586A4/en active Pending
-
2022
- 2022-03-03 IL IL291091A patent/IL291091A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10259848B2 (en) | Compositions and methods comprising hydrocarbon-stapled polypeptides | |
| CN101415723B (zh) | 具有改良生物学特性的hiv融合抑制肽 | |
| US20230399364A1 (en) | Immunogenic Coronavirus Fusion Proteins and Related Methods | |
| EP1620061B1 (en) | Antiviral agents for the treatment, control and prevention of infections by coronaviruses | |
| EP4458844A1 (en) | Anti-coronavirus polypeptide, and derivatives thereof and application thereof | |
| WO2021207848A1 (en) | Mers-cov vaccine | |
| JP2023524911A5 (enExample) | ||
| EP1797112B1 (en) | Inhibitors of hepatitits c virus | |
| JP2011521648A5 (enExample) | ||
| WO2021164576A1 (zh) | 用于抗冠状病毒感染的药物及其应用 | |
| US20030219451A1 (en) | Stable helical C peptides and uses therefor | |
| WO2023143619A1 (zh) | 一种阻断病毒侵染细胞的中和阻断剂及其制备方法和应用 | |
| ZA200509512B (en) | Antiviral agents for the treatment, control and prevention of infections by coronaviruses | |
| US20020119922A1 (en) | Peptides for inhibition of HIV infection | |
| WO2024130061A1 (en) | Immunogenic ebolavirus fusion proteins and related methods | |
| JP4188897B2 (ja) | ウィルス感染・増殖抑制剤 | |
| EP1500662A2 (en) | Stabilizing peptides |